Viemed Healthcare Inc.

NASDAQ: VMD · Real-Time Price · USD
6.81
-0.08 (-1.16%)
At close: Aug 15, 2025, 12:28 PM

Viemed Healthcare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
240.88M 232.79M 224.26M 215.7M 207.1M 195.45M 184.41M 169.78M 156.13M 146.13M 138.83M 133.29M 126.81M 120.9M 117.06M 116.3M 120.46M 135.92M
Cost of Revenue
100.72M 96.49M 91.43M 86.46M 81.67M 76.42M 71.19M 66.21M 61.48M 57.19M 54.15M 51.84M 48.64M 45.49M 43.65M 43.38M 46.47M 53.62M
Gross Profit
140.17M 136.3M 132.83M 129.24M 125.43M 119.02M 113.22M 103.57M 94.66M 88.94M 84.68M 81.45M 78.18M 75.41M 73.41M 72.93M 74M 82.3M
Operating Income
20.43M 19.21M 17.58M 16.9M 15.48M 15.09M 14.82M 12.57M 9.84M 7.94M 8.25M 9.38M 10.83M 12.5M 11.58M 12.18M 13.3M 23.5M
Interest Income
n/a n/a n/a n/a n/a 20K 69K 69K 69K 49K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
20.43M 17.71M 16.17M 15.08M 13.82M 14.63M 14.53M 12.9M 10.17M 8.5M 8.99M 10.46M 12.13M 13.55M 12.5M 12.67M 13.44M 23.39M
Net Income
13.98M 12.29M 11.27M 10.43M 9.47M 10.33M 10.24M 9.2M 7.34M 5.98M 6.22M 7.87M 8.61M 9.2M 9.13M 10.11M 11.13M 28.97M
Selling & General & Admin
119.94M 116.75M 112.26M 108.61M 105.33M 99.47M 94.37M 86.78M 80.66M 77.44M 73.36M 70.42M 66M 61.31M 60.04M 58.07M 58.3M 61.8M
Research & Development
3.2M 3.12M 3.07M 2.93M 2.77M 2.77M 2.8M 2.85M 2.93M 2.84M 2.7M 2.59M 2.49M 2.4M 2.11M 1.89M 1.56M 1.25M
Other Expenses
-1.32M -1.81M -1.78M -960.72K -523.24K 41.79K 152.79K 152.51K 346.03K 344K -11K -1.29M -1.34M -1.17M -771K 378K 199K 24K
Operating Expenses
119.52M 116.87M 115.04M 112.13M 109.46M 103.33M 98.01M 90.42M 84.23M 80.64M 76.07M 71.74M 67.16M 62.54M 61.38M 60.34M 60.24M 63.46M
Interest Expense
683K 805K 776K 885K 897K 663K 513K 289K 94K 133K 197K 234K 267K 291K 318K 349K 390K 442K
Selling & Marketing Expenses
n/a -221K -221K 419.41K 419.41K 640.41K 640.41K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
220.24M 213.36M 206.47M 198.59M 191.13M 179.75M 169.2M 156.63M 145.71M 137.84M 130.22M 123.58M 115.8M 108.03M 105.03M 103.72M 106.7M 117.08M
Income Tax Expense
6.14M 5.2M 4.76M 4.52M 4.25M 4.21M 4.19M 3.69M 2.83M 2.52M 2.77M 2.59M 3.52M 4.34M 3.38M 2.56M 2.31M -5.58M
Shares Outstanding (Basic)
39.52M 39.43M 39.03M 38.87M 38.82M 38.72M 38.49M 38.44M 38.32M 38.16M 38.02M 38.23M 38.77M 39.62M 39.64M 39.61M 39.58M 39.13M
Shares Outstanding (Diluted)
41.08M 41.63M 41.52M 40.78M 40.55M 40.58M 40.38M 40.42M 40.68M 40.02M 39.51M 39.58M 39.75M 40.36M 40.53M 40.66M 41.03M 40.66M
EPS (Basic)
0.36 0.32 0.29 0.27 0.25 0.27 0.27 0.24 0.19 0.15 0.16 0.19 0.21 0.23 0.23 0.26 0.28 0.74
EPS (Diluted)
0.33 0.29 0.27 0.26 0.24 0.26 0.26 0.23 0.18 0.15 0.15 0.19 0.20 0.22 0.22 0.24 0.27 0.71
EBITDA
47.39M 45.91M 44.15M 42.61M 41.12M 38.94M 36.91M 33.51M 28.55M 25.42M 24.71M 23.26M 23.52M 23.79M 21.76M 23.49M 24.23M 28.86M
EBIT
21.11M 19.09M 17.66M 16.54M 15.48M 15.43M 14.92M 13.1M 9.99M 8.42M 8.75M 8.54M 10.05M 11.35M 10.45M 14.93M 15.92M 21.08M
Depreciation & Amortization
26.28M 25.7M 25.37M 24.95M 24.52M 23.41M 21.89M 20.32M 18.46M 17M 15.63M 14.38M 13.12M 12.1M 11.33M 8.42M 7.97M 7.45M